Evidence map›Paper›PMID 38425217›Full record

ArticleCancer biology & medicine2024

Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.

Jian Chen, Zhe Yang, Fengqiang Gao, Zhisheng Zhou, Junli Chen, Di Lu, Kai Wang, Meihua Sui, Zhengxin Wang, Wenzhi Guo and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer biology & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Novel research horizon for liver transplantation management model in hepatocellular carcinoma based on the tumor-donor liver-recipient].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Jian Chen *Zhejiang University School of Medicine, Hangzhou 310030, China.
Zhe Yang *Institute of Organ Transplantation, Zhejiang University, Hangzhou 310030, China.
Fengqiang GaoZhejiang University School of Medicine, Hangzhou 310030, China.
Zhisheng ZhouNational Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China.
Junli ChenNational Center for Healthcare Quality Management in Liver Transplant, Hangzhou 310003, China.
Di LuZhejiang University School of Medicine, Hangzhou 310030, China.
Kai WangZhejiang University School of Medicine, Hangzhou 310030, China.
Meihua SuiZhejiang University School of Medicine, Hangzhou 310030, China.
Zhengxin WangDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Wenzhi GuoDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Guoyue LyuDepartment of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun 130021, China.
Haizhi QiDepartment of Liver Transplantation, Second Xiangya Hospital, Central South University, Changsha 410008, China.
Jinzhen CaiDepartment of Organ Transplantation Center, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
Jiayin YangDepartment of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu 610044, China.
Shusen ZhengInstitute of Organ Transplantation, Zhejiang University, Hangzhou 310030, China.ORCID 0000-0003-1459-8261
Xiao XuZhejiang University School of Medicine, Hangzhou 310030, China.ORCID 0000-0002-2761-2811
Zhejiang University · CNBlood Center of Zhejiang Province · CNCentral South University · CNFirst Affiliated Hospital of Zhengzhou University · CNFudan University · CNJilin University · CNQingdao University · CNSichuan University · CN

Funding

Key Program, National Natural Science Foundation of China 81930016Key Research & Development Program of Zhejiang Province 2019C03050Key Research & Development Program of Zhejiang Province 2021C03118Key Research & Development Program of Zhejiang Province 2022C03108National Key Research and Development Program of China 2021YFA1100500National Natural Science Foundation of China 82300743The Major Research Plan of the National Natural Science Foundation of China 92159202Zhejiang Provincial Natural Science Foundation of China LQ23H160044
6 · The paper itself

Abstract

objectiveSex-specific differences are observed in various liver diseases, but the influence of sex on the outcomes of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains to be determined. This study is the first Chinese nationwide investigation of the role of sex in post-LT outcomes in patients with HCC.

methodsData for recipients with HCC registered in the China Liver Transplant Registry between January 2015 and December 2020 were analyzed. The associations between donor, recipient, or donor-recipient transplant patterns by sex and the post-LT outcomes were studied with propensity score matching (PSM). The survival associated with different sex-based donor-recipient transplant patterns was further studied.

resultsAmong 3,769 patients enrolled in this study, the 1-, 3-, and 5-year overall survival (OS) rates of patients with HCC after LT were 96.1%, 86.4%, and 78.5%, respectively, in female recipients, and 95.8%, 79.0%, and 70.7%, respectively, in male recipients after PSM (

conclusionsOur findings highlighted that the post-LT outcomes of female recipients were significantly superior to those of male recipients, and the male-male donor-recipient transplant pattern was associated with the poorest post-LT survival. Livers from male donors may provide the most benefit to female recipients. Our results indicate that sex should be considered as a critical factor in organ allocation.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationAdultAgedChinaCohort StudiesFemaleHumansMaleMiddle AgedPropensity ScoreRegistriesRetrospective StudiesRisk FactorsSex Factorsdonorhepatocellular carcinomaliver transplantationoutcomerecipientSex

Identifiers

PMID38425217
PMCPMC11033715
OpenAlexW4392294093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.